Semaglutide commonly causes nausea, vomiting, and abdominal discomfort, while ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) can irritate the stomach lining and increase the risk of gastric ulcers and bleeding
With both dosages, the post-intervention level of malondialdehyde, a marker of lipid peroxidation, was decreased as compared to pre-intervention values
At Regenesis, we understand that your condition is unique and requires individualized care tailored to your specific needs
Reduction in binge eating Compared with placebo or other control treatments, people taking GLP-1RAs generally reported fewer binge-eating-related symptoms
Addressing this question will be important for both mechanistic refinement and more informed treatment selection in obesity management
Side effects and precautions of Semaglutide You may get nausea in the first week of taking your dose